Company intelligence / Profile preview

Accure Therapeutics

Barcelona, Catalonia, Spainaccure.health ↗

Ownership: Private
Employees: ~49
Development stage: Other

Overview

Accure Therapeutics is a private translational neuroscience R&D company based in Barcelona, Spain. Its lead program ACT‑01 (now OCS‑05), licensed to Oculis, achieved positive results in a Phase II trial for acute optic neuritis with no serious adverse events. The company has two additional programs targeting Parkinson's disease and epilepsy at earlier stages of development. Accure focuses on developing first-in-class small molecule drugs that address unmet needs in central nervous system disorders through innovative mechanisms and strategic partnerships.

Therapeutic areas: Neurology
Modalities: Small molecules (new chemical entities)
Industry: Biotech

Drug pipeline

2 assets

ACT-02

Preclinical

1 more asset in the full pipeline.

Partnerships

Oculis Holding AG – licensing partner for ACT‑01/OCS‑05Academic partners including Universitat de Barcelona and CERCA/CSIC centers

Beyond the preview

Go deeper on Accure Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Accure Therapeutics.